0000000000343312

AUTHOR

Tatjana Baldovin

showing 6 related works from this author

Prevalence of Pneumococcal Serotypes in Community-Acquired Pneumonia among Older Adults in Italy: A Multicenter Cohort Study

2022

Pneumococcal community-acquired pneumonia (CAP) is a leading cause of mortality. Following the introduction of pneumococcal conjugate vaccines (PCVs) in children, a decrease in the burden of the disease was reported. In parallel, an increase in non-vaccine serotypes was also noted. The objective of this study was to assess the current serotype-specific epidemiology of pneumococci among Italian older adults hospitalized for CAP. A prospective study was conducted between 2017 and 2020 in four Italian regions. Subjects aged ≥65 years hospitalized with confirmed CAP were tested for pneumococci using both pneumococcal urinary antigen and serotype-specific urine antigen tests able to identify all…

pneumococcal conjugate vaccinecommunity-acquired pneumonia (CAP); older adults; pneumococcal conjugate vaccines; pneumococcal pneumonia; Streptococcus pneumoniaeMicrobiology (medical)Streptococcus pneumoniaepneumococcal pneumoniaVirologypneumococcal conjugate vaccinescommunity-acquired pneumonia (CAP)community-acquired pneumonia (CAP); <i>Streptococcus pneumoniae</i>; pneumococcal pneumonia; pneumococcal conjugate vaccines; older adultsSettore MED/42 - Igiene Generale E ApplicataMicrobiologyolder adultsMicroorganisms
researchProduct

Evaluation of humoral and cellular response to four vaccines against COVID-19 in different age groups: A longitudinal study

2022

To date there has been limited head-to-head evaluation of immune responses to different types of COVID-19 vaccines. A real-world population-based longitudinal study was designed with the aim to define the magnitude and duration of immunity induced by each of four different COVID-19 vaccines available in Italy at the time of this study. Overall, 2497 individuals were enrolled at time of their first vaccination (T0). Vaccine-specific antibody responses induced over time by Comirnaty, Spikevax, Vaxzevria, Janssen Ad26.COV2.S and heterologous vaccination were compared up to six months after immunization. On a subset of Comirnaty vaccinees, serology data were correlated with the ability to neutr…

COVID-19 VaccinesAd26COVS1vaccines.SARS-CoV-2ImmunologyCOVID-19serologyViral VaccinesvaccinesHumansB-cell memory; COVID-19; cell-mediated immunity; serology; vaccinescell-mediated immunityImmunology and AllergyB-CELL MEMORY COVID-19 CELL-MEDIATED IMMUNITY SEROLOGY VACCINESB-cell memoryLongitudinal StudiesB-cell memory; COVID-19; cell-mediated immunity; serology; vaccines; Humans; Aged; COVID-19 Vaccines; Longitudinal Studies; Ad26COVS1; SARS-CoV-2; COVID-19; Viral VaccinesAgedFrontiers in Immunology
researchProduct

Predicting needlestick and sharps injuries in nursing students: Development of the SNNIP scale

2020

© 2020 The Authors. Nursing Open published by John Wiley & Sons Ltd. Aim: To develop an instrument to investigate knowledge and predictive factors of needlestick and sharps injuries (NSIs) in nursing students during clinical placements. Design: Instrument development and cross-sectional study for psychometric testing. Methods: A self-administered instrument including demographic data, injury epidemiology and predictive factors of NSIs was developed between October 2018–January 2019. Content validity was assessed by a panel of experts. The instrument's factor structure and discriminant validity were explored using principal components analysis. The STROBE guidelines were followed. Results: E…

cross-sectionalknowledgePsychometricsFactor structurenursing studentSettore MED/44 - MEDICINA DEL LAVORONursingpreventionSurveys and QuestionnairesContent validityneedlestickMedicineHealth belief modelHumanssharps injuriePsychometric testingNeedlestick InjuriesGeneral NursingResearch Articlesnursing studentslcsh:RT1-120validationlcsh:Nursingbusiness.industryInjury epidemiologyquestionnairesharps injuriesDiscriminant validityExploratory factor analysisCross-Sectional StudiesScale (social sciences)Students Nursingcross‐sectionalbusinesscross-sectional; Health Belief Model; knowledge; needlestick; nursing students; prevention; questionnaire; sharps injuries; validationResearch ArticleHealth Belief Model
researchProduct

Control and prevention measures for legionellosis in hospitals: A cross-sectional survey in Italy

2018

Abstract Risk assessment, environmental monitoring, and the disinfection of water systems are the key elements in preventing legionellosis risk. The Italian Study Group of Hospital Hygiene of the Italian Society of Hygiene, Preventive Medicine, and Public Health and the Italian Multidisciplinary Society for the Prevention of Health Care-Associated Infections carried out a national cross-sectional survey to investigate the measures taken to prevent and control legionellosis in Italian hospitals. A multiple-choice questionnaire was developed, comprising 71 questions regarding hospital location, general characteristics, clinical and environmental surveillance, and control and preventive measur…

0301 basic medicinemedicine.medical_specialtyCross-sectional studyLegionellamedia_common.quotation_subject030106 microbiologyControl measuresBiochemistryControl measures; Hospital; Legionellosis; National survey; Prevention; Biochemistry; 2300Legionella pneumophila03 medical and health sciencesHospital0302 clinical medicineControl measures; Hospital; Legionellosis; National survey; Prevention; Cross Infection; Cross-Sectional Studies; Disinfection; Humans; Infection Control; Italy; Legionella pneumophila; Legionellosis; Surveys and Questionnaires; Water Microbiology; Water SupplyHygieneWater SupplyLegionellosiSurveys and Questionnairesmedicinecontrol measures; hospital; legionellosis; national survey; preventionControl measures Hospital Legionellosis National survey Prevention Biochemistry 2300Humans030212 general & internal medicineSeroconversionGeneral Environmental SciencePreventive healthcaremedia_commonResponse rate (survey)National surveyCross InfectionInfection ControlLegionellosisbiology2300business.industryPublic healthPreventionControl measurebiology.organism_classificationDisinfectionCross-Sectional StudiesItalyEmergency medicinebusinessRisk assessmentWater Microbiology
researchProduct

Wastewater surveillance of SARS-CoV-2 variants in October-November 2022 in Italy: detection of XBB.1, BA.2.75 and rapid spread of the BQ.1 lineage

2023

This study adds insight regarding the occurrence and spread of SARS-CoV-2 Variants of Concern (VOCs) and Var-iants of Interest (VOIs) in Italy in October and November 2022, by testing urban wastewater collected through-out the country. A total of 332 wastewater samples were collected from 20 Italian Regions/Autonomous Provinces (APs) within the framework of national SARS-CoV-2 environmental surveillance. Of these, 164 were collected in the first week of October and 168 in the first week of November. A similar to 1600 bp fragment of the spike protein was sequenced by Sanger (for individual samples) and long-read nanopore sequencing (for pooled Region/AP samples).In October, mutations charact…

BA2.75Environmental EngineeringSurveillanceMED/42 - IGIENE GENERALE E APPLICATAOmicronSARS-CoV-2BQ.1BA2.75; BQ.1; Omicron; SARS-CoV-2; Surveillance; Wastewater; XBB.1WastewaterBIO/19 - MICROBIOLOGIA GENERALEPollutionMED/07 - MICROBIOLOGIA E MICROBIOLOGIA CLINICABA2.75 BQ.1 Omicron SARS-CoV-2 Surveillance Wastewater XBB.1XBB.1Environmental ChemistryWaste Management and Disposal
researchProduct

Sero-Epidemiological Study of Varicella in the Italian General Population.

2023

The aim of this study was to analyze the seroprevalence of varicella in Italy and to evaluate the impact of varicella vaccination, which has been mandatory for newborns since 2017. The levels of VZV-specific IgG antibodies were determined by the ELISA method in residual serum samples obtained from subjects aged between 6 and 64 years and residing in 13 Italian regions. Overall, 3746 serum samples were collected in the years 2019 and 2020. The overall seroprevalence was 91.6% (89.9% in males and 93.3% in females; p = 0.0002). Seroprevalence showed an increasing trend (p &lt; 0.0001) starting in the younger age groups: 6&ndash;9 years: 84.1%; 10&ndash;14 years: 88.7%; 15&ndash;19 years: 89.3%…

PharmacologyInfectious DiseasesvaricellaItaly; general population; immunization; sero-epidemiology; varicellaItalysero-epidemiologyDrug DiscoveryImmunologyPharmacology (medical)immunizationSettore MED/42 - Igiene Generale E Applicatavaricella sero-epidemiology Italy general population immunizationgeneral population
researchProduct